RVLP(Delisted)
RVL Pharmaceuticals·NASDAQ
--
--(--)
RVLP Filings
Filing Date
Form Description
Form Type
2024-02-13
Form 8-K - Current report
Key Events
2024-02-13 · Key Events
Form 8-K - Current report
2024-01-17
Form 8-K - Current report
Key Events
2024-01-17 · Key Events
Form 8-K - Current report
2023-12-20
Form 8-K - Current report
Key Events
2023-12-20 · Key Events
Form 8-K - Current report
2023-11-28
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Ownership
2023-11-28 · Ownership
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023-11-27
Form 8-K - Current report
Key Events
2023-11-27 · Key Events
Form 8-K - Current report
2023-11-20
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Key Events
2023-11-20 · Key Events
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023-11-16
Form DEF 14A - Other definitive proxy statements
Key Events
2023-11-16 · Key Events
Form DEF 14A - Other definitive proxy statements
2023-11-06
Form PRE 14A - Other preliminary proxy statements
Key Events
2023-11-06 · Key Events
Form PRE 14A - Other preliminary proxy statements
2023-11-06
Form 8-K - Current report
Key Events
2023-11-06 · Key Events
Form 8-K - Current report
2023-11-01
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Ownership
2023-11-01 · Ownership
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
